Research
Molecular
GLP-1 receptor agonist patients had significantly lower serum albumin (4.06 g/dL) and prealbumin levels (23.52 mg/dL) compared to controls (4.22 g/dL and 25.55 mg/dL, respectively).
Monitoring nutritional status, including serum albumin and prealbumin, may be important for patients on GLP-1 receptor agonists.
StrongSupportsmedium confidence
GLP-1 patients had significantly lower serum albumin (4.06 ± 0.22 vs. 4.22 ± 0.17 g/dL, p=0.003) and prealbumin levels (23.52 ± 3.39 vs. 25.55 ± 3.10 mg/dL, p=0.02).
Why this rating
Based on a retrospective comparative case series design.
Source
Breast implant explantation with mastopexy in patients using GLP-1 receptor agonizts: A retrospective comparative analysis
Or Friedman et al. · Journal of Plastic Reconstructive & Aesthetic Surgery · 2025
DOI 10.1016/j.bjps.2025.09.028
other · n=60Cited 5×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- GLP-1 receptor agonist patients demonstrated higher overall complication rates (20%) compared to controls (10%), though this was not statistically significant (p=0.47).Strong
- GLP-1 receptor agonist patients experienced greater weight loss (7.8 kg) compared to controls (0.5 kg), with statistical significance (p<0.001).Strong
Related findings · Molecular
- QRISK decreased markedly after weight loss from 18.9 ± 2.2% to 11.2 ± 1.6%, p < 0.0001.Strong
- Normalization of 10-year cardiovascular risk and heart age is possible after substantial dietary weight loss and remission of T2DM.Strong
- The Low-Fat Plus diet resulted in a greater reduction in total cholesterol compared to the Low-Fat diet, with changes of -0.46 mmol/L (-17.6 mg/dL) versus -0.24 mmol/L (-9.2 mg/dL) respectively (P = 0.01).Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →